Onconova Therapeutics is a biopharmaceutical company that primarily focusses on developing novel treatments for cancer, with two clinical-stage programs currently being researched. The company is also developing a preclinical program for potential COVID-19 treatment options. Onconova has multiple license and collaboration agreements with other biopharmaceutical companies to help bring their treatments to market.